HEALTH authorities in Hwange district, Matabeleland North Province are targeting key populations in their Cabotegravir (CABLA) pilot programme to reduce new HIV infections. CAB-LA, is a long-acting injectable pre-exposure prophylaxis(PrEP) medication used for short-term prevention of HIV/Aids. Hwange district medical officer, Fungai Musinami told the Daily News that authorities in the district were scaling up…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions